Alabama Workplace Cannabis Protections — None (At-Will + Compassion Act Carveout)

Alabama provides no workplace protections for medical-cannabis patients. The Compassion Act § 20-2A-7 expressly preserves employer drug-free-workplace policies and the right to refuse to accommodate medical-cannabis use. Alabama is an at-will employment state. Workers’ comp may be denied for impairment + positive THC test under the Drug-Free Workplace Act § 25-5-330 et seq. Pre-employment, random, post-accident, and reasonable-suspicion testing all permitted. THC’s 30+ day detection window means out-of-state legal use can cost an Alabama job.

Last verified: May 2026

The Compassion Act’s Express Employer Carveout

Alabama Code § 20-2A-7 expressly preserves employer rights regarding cannabis-using employees. The statute provides that nothing in the Compassion Act:

  • Requires an employer to permit, accommodate, or take any other action regarding medical cannabis in the workplace.
  • Limits an employer’s right to maintain a drug-free workplace.
  • Limits an employer’s right to discharge or take adverse employment action against an employee for cannabis use, including medical-cannabis use authorized under the Compassion Act.
  • Affects the employer’s ability to enforce workplace drug-testing policies, including pre-employment, random, post-accident, and reasonable-suspicion testing.

The carveout was a deliberate concession during the 2021 legislative process. Conservative legislators argued that mandating employment accommodations would impose substantial new compliance costs on Alabama employers and would interfere with employer-driven safety programs. The carveout addressed those concerns explicitly.

Alabama as an At-Will Employment State

Alabama is one of the strictest at-will employment states. The doctrine permits an employer to terminate an employee at any time, for any reason or no reason, with very narrow statutory exceptions:

  • Title VII protected classifications — race, color, religion, sex, national origin (federal).
  • Age discrimination — ADEA for 40+ (federal).
  • Disability discrimination — ADA (federal). Cannabis users are not protected even with documented Compassion Act condition; cannabis use is not a disability under ADA, and Schedule I status currently disqualifies medical-cannabis users from ADA protection.
  • FMLA leave — for serious health condition treatment (federal).
  • Workers’ comp retaliation — Alabama Code § 25-5-11.1 (state).
  • Public-policy exception — Alabama recognizes very narrow public-policy exceptions (whistleblowing on illegal activity, refusing to commit crimes); Compassion Act registration is not a public-policy exception.

The at-will doctrine + Compassion Act § 20-2A-7 carveout means Alabama employers can fire registered medical-cannabis patients for positive THC tests with virtually no legal exposure.

Workers’ Compensation Denial — § 25-5-51 / Alabama Drug-Free Workplace Act

Alabama Code § 25-5-51(a) provides that an employee is barred from workers’ compensation if the injury was proximately caused by the employee’s impairment from a controlled substance. The Alabama Drug-Free Workplace Act (§ 25-5-330 et seq.) creates a rebuttable presumption that an injury was caused by impairment if the employee tests positive for a controlled substance after the injury. The presumption shifts the burden to the employee to prove that impairment was not the cause.

For Compassion Act registrants, the presumption is particularly problematic because:

  • THC and THC metabolites are detectable for days to weeks after use.
  • A medical-cannabis patient may have detectable THC at time of injury without being clinically impaired at injury time.
  • Rebutting the presumption requires expert testimony on impairment vs. detection — an expensive and uncertain process.
  • Patients who suffer workplace injuries face simultaneous risks: termination + workers’ comp denial + medical-bills exposure.

Drug-Testing Modalities

Alabama employers can lawfully conduct:

  • Pre-employment testing. Standard for federal contractors, federal employees, manufacturing employers, healthcare employers, and many service-sector employers. Compassion Act registrants face pre-employment-test failures regardless of card status.
  • Random testing. Standard for federal-employee positions, federally-regulated transportation positions (DOT, FAA, FMCSA), and many manufacturing-safety positions.
  • Post-accident testing. Mandatory for OSHA-regulated workplaces after injuries; standard for many other employers.
  • Reasonable-suspicion testing. Permitted when an employer has reasonable basis to believe an employee is impaired.
  • Return-to-duty / follow-up testing. Following a positive test or return from substance-abuse program.

The Federal Layer — DOT, FAA, FMCSA, Federal Employees

Federal positions have stricter cannabis-testing requirements than Alabama state law:

  • Federal employees — Executive Order 12564 (Reagan, 1986) requires drug-free federal workplace. Cannabis use is grounds for removal regardless of state authorization.
  • Federal contractors — FAR 52.223-6 imposes drug-free-workplace requirements on contractors.
  • DOT-regulated commercial drivers — 49 CFR Part 382 categorically prohibits cannabis use. Positive test = automatic disqualification.
  • FAA-regulated aviation positions — 14 CFR Part 120 categorically prohibits cannabis use. Positive test = airman certificate revocation.
  • FMCSA-regulated commercial drivers — 49 CFR § 382.305 random testing; positive test = disqualification.
  • Federal cleared positions — SF-86 / continuous-vetting issues.

The April 2026 Schedule III Order — Limited Effect

Acting AG Todd Blanche’s April 23, 2026 order moved cannabis from Schedule I to Schedule III under federal law. The order does not directly modify federal-employee or federal-contractor drug-testing requirements. Executive Order 12564, FAR 52.223-6, and the federally-regulated transportation rules continue to treat cannabis as a prohibited substance regardless of schedule.

The federal Department of Transportation (DOT) has not yet revised its drug-testing rules in response to the schedule change. The federal employee drug-testing program (administered by HHS) has not yet revised guidelines. The schedule change’s practical effect on federal-employer drug-testing remains pending.

Practical Patient Notes

  • The Compassion Act card does not protect your job. Employers can fire registered patients for positive THC tests.
  • Federal positions face stricter prohibition. Compassion Act registration is not a defense for any federal-employee, federal-contractor, or federally-regulated position.
  • Workers’ comp may be denied. Positive post-accident THC test creates rebuttable presumption that impairment caused the injury.
  • Discuss alternative medications with your physician. If your job exposure is high, cannabis may not be the right medication choice.
  • Document your dosing carefully. If you do use, track the timing relative to potential testing exposure. THC detection windows can extend 30+ days for chronic users.